NCT03406689View on ClinicalTrials.gov

Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

March 28, 2018

Conditions

Pain

Interventions

DRUG

Nepafenac 0.1% Oph Susp

One drop of Nepafenac 0.1% will be instilled 45' prior to the IVI.

DRUG

Nepafenac 0.3% Oph Susp

One drop of Nepafenac 0.3% will be instilled 45' prior to the IVI.

DRUG

Artificial tear

One drop Artificial Tears will be instilled 45' prior to the IVI.

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors

lead

University Hospital of Patras

OTHER

NCT03406689 - Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections | Biotech Hunter | Biotech Hunter